Health Catalyst, Inc. — Director's Dealing 2020

Sep 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2020-09-15

Reporting Person: Orenstein Daniel H. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-15	Common Stock	M	5000.00	$10.34	Acquired	45000.00	Direct
2020-09-15	Common Stock	S	4400.00	$35.6054	Disposed	40600.00	Direct
2020-09-15	Common Stock	S	600.00	$36.3017	Disposed	40000.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-15	Stock Option (Right to Buy)	$10.34	M	5000.00	Disposed	2026-02-10	Common Stock (5000.00)	Direct

Footnotes

F1: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 4, 2020, in accordance with Rule 10b5-1.

F2: Represents the weighted average sale price of the shares sold ranging from $35.24 to $36.23 per share, inclusive.

F3: Represents the weighted average sale price of the shares sold ranging from $36.25 to $36.40 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and footnote 2.

F4: 25% of the shares vested on December 31, 2016 and the remaining 75% vested in 36 equal monthly installments thereafter until the option was vested in full on Dec. 31, 2019.